Hacettepe University Medical Faculty Hospital

Ankara 6230

2 studies enrolling now · 6 studies all time

What they study most

ASAH1 Mutation, Acid Ceramidase Deficiency, COVID-19, Ceramidase Deficiency, Extensive-stage Small-cell Lung Cancer, Farber Disease, Farber Lipogranulomatosis, Farber's Disease, Hemophilia A, Hemophilia B, Known or Suspected Focal Liver Lesions, N-Laurylsphingosine Deacylase Deficiency

Studies at this site

• Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer — Recruiting now
• Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors — Recruiting now
• EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19 — Completed
• Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function — Completed
• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early
• Farber Disease Natural History Study — Completed